| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |